107 related articles for article (PubMed ID: 29115187)
1. Hyaluronate - parathyroid hormone peptide conjugate for transdermal treatment of osteoporosis.
Cho M; Han S; Kim H; Kim KS; Hahn SK
J Biomater Sci Polym Ed; 2018; 29(7-9):793-804. PubMed ID: 29115187
[TBL] [Abstract][Full Text] [Related]
2. Transdermal delivery of hyaluronic acid -- human growth hormone conjugate.
Yang JA; Kim ES; Kwon JH; Kim H; Shin JH; Yun SH; Choi KY; Hahn SK
Biomaterials; 2012 Sep; 33(25):5947-54. PubMed ID: 22632765
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronate-Epidermal Growth Factor Conjugate for Skin Wound Healing and Regeneration.
Kim H; Kong WH; Seong KY; Sung DK; Jeong H; Kim JK; Yang SY; Hahn SK
Biomacromolecules; 2016 Nov; 17(11):3694-3705. PubMed ID: 27775884
[TBL] [Abstract][Full Text] [Related]
4. Targeted systemic mesenchymal stem cell delivery using hyaluronate - wheat germ agglutinin conjugate.
Kim YS; Kong WH; Kim H; Hahn SK
Biomaterials; 2016 Nov; 106():217-27. PubMed ID: 27569867
[TBL] [Abstract][Full Text] [Related]
5. Preparation and in vivo evaluation of an orally available enteric-microencapsulated parathyroid hormone (1-34)-deoxycholic acid nanocomplex.
Hwang SR; Seo DH; Byun Y; Park JW
Int J Nanomedicine; 2016; 11():4231-46. PubMed ID: 27621618
[TBL] [Abstract][Full Text] [Related]
6. Nose-to-brain delivery of hyaluronate - FG loop peptide conjugate for non-invasive hypoxic-ischemic encephalopathy therapy.
Kim YS; Sung DK; Kim H; Kong WH; Kim YE; Hahn SK
J Control Release; 2019 Aug; 307():76-89. PubMed ID: 31229472
[TBL] [Abstract][Full Text] [Related]
7. Study on preparation and activity of a novel recombinant human parathyroid hormone(1-34) analog with N-terminal Pro-Pro extension.
Chunxiao W; Jingjing L; Yire X; Min D; Zhaohui W; Gaofu Q; Xiangchun S; Xuejun W; Jie W; Taiming L
Regul Pept; 2007 Jun; 141(1-3):35-43. PubMed ID: 17300845
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization, and preliminary assessment of anti-Flt1 peptide-hyaluronate conjugate for the treatment of corneal neovascularization.
Oh EJ; Park K; Choi JS; Joo CK; Hahn SK
Biomaterials; 2009 Oct; 30(30):6026-34. PubMed ID: 19647313
[TBL] [Abstract][Full Text] [Related]
9. Cooperative interaction of arginine-19 and the N-terminal signaling domain in the affinity and potency of parathyroid hormone.
Tsomaia N; Shimizu M; Shimizu N; Gardella TJ; Mierke DF
Biochemistry; 2004 Mar; 43(12):3459-70. PubMed ID: 15035617
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the effects of parathyroid hormone and parathyroid hormone-related protein on osteocalcin in the rat.
Gundberg CM; Fawzi MI; Clough ME; Calvo MS
J Bone Miner Res; 1995 Jun; 10(6):903-9. PubMed ID: 7572314
[TBL] [Abstract][Full Text] [Related]
11. Bone regeneration using a synthetic matrix containing a parathyroid hormone peptide combined with a grafting material.
Jung RE; Hämmerle CH; Kokovic V; Weber FE
Int J Oral Maxillofac Implants; 2007; 22(2):258-66. PubMed ID: 17465351
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid-tumor necrosis factor-related apoptosis-inducing ligand conjugate for targeted treatment of liver fibrosis.
Yang JA; Kong WH; Sung DK; Kim H; Kim TH; Lee KC; Hahn SK
Acta Biomater; 2015 Jan; 12():174-182. PubMed ID: 25305513
[TBL] [Abstract][Full Text] [Related]
13. Signal transduction of hyaluronic acid-peptide conjugate for formyl peptide receptor like 1 receptor.
Oh EJ; Kim JW; Kong JH; Ryu SH; Hahn SK
Bioconjug Chem; 2008 Dec; 19(12):2401-8. PubMed ID: 19007292
[TBL] [Abstract][Full Text] [Related]
14. Tuberoinfundibular peptide (7-39) [TIP(7-39)], a novel, selective, high-affinity antagonist for the parathyroid hormone-1 receptor with no detectable agonist activity.
Hoare SR; Usdin TB
J Pharmacol Exp Ther; 2000 Nov; 295(2):761-70. PubMed ID: 11046116
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone and parathyroid hormone-related protein: model systems for the development of an osteoporosis therapy.
Mierke DF; Pellegrini M
Curr Pharm Des; 1999 Jan; 5(1):21-36. PubMed ID: 10066882
[TBL] [Abstract][Full Text] [Related]
16. [Algal oligosaccharides ameliorate osteoporosis via up-regulation of parathyroid hormone 1-84 and vascular endothelial growth factor].
Wang L; Wang H; Fang N
J Tradit Chin Med; 2016 Jun; 36(3):332-9. PubMed ID: 27468548
[TBL] [Abstract][Full Text] [Related]
17. Validation and application of an immunoradiometric assay for the determination of human parathyroid hormone fragment 1-34 in dog plasma following subcutaneous and intravenous administration.
Seibel MW; Lade DA; Hartke JR; Wehmeyer KR
J Pharm Biomed Anal; 1996 Sep; 14(12):1699-707. PubMed ID: 8887717
[TBL] [Abstract][Full Text] [Related]
18. Two-photon microscopy of a Flt1 peptide-hyaluronate conjugate.
Beack S; Choi JS; Lee JH; Kim H; Kim KH; Joo CK; Hahn SK
Nanomedicine (Lond); 2015; 10(15):2315-24. PubMed ID: 26228271
[TBL] [Abstract][Full Text] [Related]
19. Target specific hyaluronic acid-interferon alpha conjugate for the treatment of hepatitis C virus infection.
Yang JA; Park K; Jung H; Kim H; Hong SW; Yoon SK; Hahn SK
Biomaterials; 2011 Nov; 32(33):8722-9. PubMed ID: 21872329
[TBL] [Abstract][Full Text] [Related]
20. Self-adjuvanted hyaluronate--antigenic peptide conjugate for transdermal treatment of muscular dystrophy.
Kong WH; Sung DK; Kim H; Yang JA; Ieronimakis N; Kim KS; Lee J; Kim DH; Yun SH; Hahn SK
Biomaterials; 2016 Mar; 81():93-103. PubMed ID: 26724457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
